The hepatitis C virus modulates insulin signaling pathway in vitro promoting insulin resistance

PLoS One. 2012;7(10):e47904. doi: 10.1371/journal.pone.0047904. Epub 2012 Oct 25.

Abstract

Insulin is critical for controlling energy functions including glucose and lipid metabolism. Insulin resistance seems to interact with hepatitis C promoting fibrosis progression and impairing sustained virological response to peginterferon and ribavirin. The main aim was to elucidate the direct effect of hepatitis C virus (HCV) infection on insulin signaling both in vitro analyzing gene expression and protein abundance. Huh7.5 cells and JFH-1 viral particles were used for in vitro studies. Experiments were conducted by triplicate in control cells and infected cells. Genes and proteins involved in insulin signaling pathway were modified by HCV infection. Moreover, metformin treatment increased gene expression of PI3K, IRS1, MAP3K, AKT and PTEN more than >1.5 fold. PTP1B, encoding a tyrosin phosphatase, was found highly induced (>3 fold) in infected cells treated with metformin. However, PTP1B protein expression was reduced in metformin treated cells after JFH1 infection. Other proteins related to insulin pathway like Akt, PTEN and phosphorylated MTOR were also found down-regulated. Viral replication was inhibited in vitro by metformin. A strong effect of HCV infection on insulin pathway-related gene and protein expression was found in vitro. These results could lead to the identification of new therapeutic targets in HCV infection and its co-morbidities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Comorbidity
  • Gene Expression Profiling
  • Gene Expression Regulation
  • Gene Expression Regulation, Viral
  • Hepacivirus / metabolism*
  • Hepatitis C / metabolism
  • Humans
  • In Vitro Techniques
  • Insulin / metabolism*
  • Insulin Resistance*
  • Metformin / pharmacology
  • Models, Biological
  • Models, Statistical
  • Signal Transduction

Substances

  • Insulin
  • Metformin

Grants and funding

This work was supported by grant PI10/0611 from Instituto de Salud Carlos III, Spanish Ministry of Economy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.